Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Carcinoma, Basal Cell
Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Neoplasms, Basal Cell » Carcinoma, Basal Cell
Description
A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) MeSH
Hierarchy View
Subtype Terms (1)
Basal Cell Nevus Syndrome
17 drugs (13 approved, 4 experimental)
Approved Indicated Drugs (4)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (33)
Other Experimental Indicated Drugs (10)
Organization Involved with Phase 4 Indications (10)
Organization Involved with Phase 3 Indications (12)
Organization Involved with Phase 2 Indications (54)
Canadian Institutes of Health Research (CIHR)
Cantonal Hospital of St. Gallen
Icahn School of Medicine at Mount Sinai
Memorial Sloan-Kettering Cancer Center
National Cancer Institute (NCI)
Organization Involved with Phase 1 Indications (30)
Organization Involved with Other Experimental Indications (15)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.